IP Library Granted Patent US 8,288,093
Granted Patent B2
US 8,288,093 · App. 12/099,656 · Granted Oct 16, 2012

Detection of nucleic acids by multiple sequential invasive cleavages

Assignee: Third Wave Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,288,093
App. No.
12/099,656
Granted
Oct 16, 2012
Kind
B2
Abstract

The present invention relates to means for the detection and characterization of nucleic acid sequences, as well as variations in nucleic acid sequences. The present invention also relates to methods for forming a nucleic acid cleavage structure on a target sequence and cleaving the nucleic acid cleavage structure in a site-specific manner. The structure-specific nuclease activity of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations thereof. The present invention further relates to methods and devices for the separation of nucleic acid molecules based on charge. The present invention also provides methods for the detection of non-target cleavage products via the formation of a complete and activated protein binding region. The invention further provides sensitive and specific methods for the detection of human cytomegalovirus nucleic acid in a sample.

Claims (18)

1. A method comprising:

a) providing:

i) a first complex comprising a first nucleic acid, a second nucleic acid and a third nucleic acid, said first nucleic acid comprising a first portion and said second nucleic acid comprising a first region and a second region, wherein said first region of said second nucleic acid is 5′ of said second region of said second nucleic acid, and wherein said first portion of said first nucleic acid is hybridized to said first region of said second nucleic acid, and wherein at least a portion of said third nucleic acid is hybridized to said second region of said second nucleic acid; and

ii) a fourth nucleic acid comprising a hairpin structure and a detectable label;

b) cleaving said first complex thereby generating a first cleavage product, wherein the amount of said first cleavage product increases at a first rate, and increases as a function of time;

c) hybridizing at least a portion of said first cleavage product to at least a portion of said fourth nucleic acid thereby forming a second complex;

d) cleaving said fourth nucleic acid in said second complex thereby generating a second cleavage product comprising said detectable label, wherein the amount of said second cleavage product increases at a second rate, and increases as a function of time; and

e) detecting the amount of said second cleavage product; and

f) determining said second rate.

2. The method of claim 1 , wherein said first rate and said second rate are different.

3. The method of claim 2 , wherein said first rate is a linear rate.

4. The method of claim 2 , wherein said second rate is an exponential rate.

5. The method of claim 1 , wherein said second cleavage product is generated by cleaving said hairpin structure.

6. The method of claim 1 , wherein said detectable label is a first fluorophore, and wherein detecting the amount of said second cleavage product comprises detection of fluorescence from said first fluorophore.

7. The method of claim 6 , wherein said fourth nucleic acid further comprises a second fluorphore, said second fluorphore is a quencher of said first fluorophore, and wherein said determining said second rate comprises detection of a change in said fluorescence from said first fluorophore.

8. The method of claim 7 , wherein said change in said fluorescence is a change in fluorescence intensity.

9. The method of claim 8 , wherein said change in fluorescence intensity is an increase in fluorescence intensity.

10. The method of claim 1 , wherein said second nucleic acid in said first complex comprises a nucleic acid from human cytomegalovirus.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2008
From: HALL, JEFF G.; LYAMICHEV, VICTOR I.; MAST, ANDREA L.; BROW, MARY ANN D.
To: THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 021331/0114 →
SECURITY AGREEMENT Recorded Jul 29, 2008
From: THIRD WAVE TECHNOLOGIES, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021301/0780 →
Continuity (9)
Division 10033297 · Nov 12, 2001
Continuation 09350597 · Jul 9, 1999
Continuation 08823516 · Mar 24, 1997
Continuation In Part PCTUS9701072 · Jan 22, 1997
Continuation In Part 08759038 · Dec 2, 1996
Continuation In Part 08756386 · Nov 26, 1996
Continuation In Part 08682853 · Jul 12, 1996
Continuation In Part 08599491 · Jan 24, 1996
Related Publication 20080268455A1 · Oct 30, 2008